The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.

Because the virus evolves so rapidly, having it once doesn’t provide much long-term immunity. And it also doesn’t help that there’s not a vaccine for norovirus yet. People with Type O blood ...

Pulmonary fibrosis in patients with COVID-19 tends to resolve, while idiopathic pulmonary fibrosis always progresses.

IPF affects the tissue surrounding the air sacs, or alveoli, in the lungs. This condition develops when lung tissue becomes ...

Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it.

It turns out that vaccine durability has much to do with a type of blood cell called megakaryocytes ... yellow fever, malaria and COVID-19. The same signs of megakaryocyte activation were ...

The findings could also offer insights into the potential and limits of alternative ways to create immunity ... blood cells vital for immune defense. In healthy individuals, mRNA COVID-19 vaccines ...

But it quickly became apparent that SARS-CoV-2, the virus that causes COVID-19, was so much ... A macrophage is a type of white blood cell that stimulates other immune system cells.